The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Ubigene Biosciences
New York, United States
B
51-100 Employees
-
Key takeaway
Ubigene is dedicated to making genome editing easier, offering advanced gene-editing services and products. Their innovative CRISPR-U™ technology significantly enhances gene-editing efficiency, and they provide a comprehensive automated design system that supports researchers in this field.
Highlighted product
Service
| Ubigene
Axolabs
Kulmbach, Germany
A
11-50 Employees
2007
Key takeaway
Axolabs is a leading service provider specializing in the discovery, development, and manufacture of therapeutics based on DNA or RNA, with over 20 years of expertise in oligonucleotide research. Their integrated solutions encompass all stages of research and development, ensuring high-quality services and products for the successful development of nucleic acid-based therapeutics, including gene editing.
Highlighted product
Service
Gene Editing / Axolabs
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene has developed a leading genome editing platform and is now prepared to collaborate in the therapeutics sector, highlighting its commitment to advancing cures through innovative gene editing technologies.
Highlighted product
Core business
TARGETGENE – DEVELOPING THE WORLD’S BEST THERAPEUTIC GENOME EDITING PLATFORM
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Edilytics
Cambridge, United States
B
1-10 Employees
2019
Key takeaway
Edilytics offers advanced precision genome editing solutions, highlighting CRISPResso2 as a trusted tool for analyzing gene editing experiments. This platform provides comprehensive data and user-friendly features, making it suitable for both academia and industry.
Highlighted product
Core business
Edilytics | Precision Genome Editing Analysis
Inscripta
Boulder, United States
B
101-250 Employees
2015
Key takeaway
The company highlights its innovative approach to gene editing through methods like CRISPR and Directed Evolution, which enhance biomanufacturing and enable the discovery of beneficial genetic changes. Their digital genome engineering tools promise to transform various fields, including material production, agriculture, and disease treatment.
Highlighted product
Product
Genome Editing - Inscripta®
Our revolutionary digital genome engineering tools transform how we face complex global challenges and yield solutions that benefit all.
Creative Biogene
-
- Employees
-
Key takeaway
Creative Biogene specializes in developing high-quality products and technologies that support research in basic life sciences, including gene editing. They offer customized gene editing kits and professional technical services to facilitate microbial research and preclinical drug discovery.
Highlighted product
Product
Gene Editing Kits - Creative Biogene
Scribe Therapeutics
United States
B
11-50 Employees
2017
Key takeaway
The company is focused on advancing gene editing through innovative delivery technologies that enhance in vivo genetic medicine. Their approach emphasizes precision targeting within the genome, which is essential for developing effective therapies.
Highlighted product
Core business
Scribe
CRISPR AgroBio News (CARBON)
Copenhagen, Denmark
A
1-10 Employees
2022
Key takeaway
Biomedrex Genetics is dedicated to advancing innovation in gene therapy and genome editing, specifically highlighting the use of CRISPR and other gene editing tools. Their focus includes delivering comprehensive information on the latest developments, safety, and clinical applications in the field.
Highlighted product
Core business
Company: Biomedrex Genetics
More than 100 companies to follow in 2023 working with a gene editing tool like CRISPR, TALEN, ZFN, Prime Editor, Base Editor, MegaNuclease...
Alliance Regenerative Medicine
Washington, United States
B
11-50 Employees
2009
Key takeaway
The company is focused on advancing gene therapies, which are a key component of regenerative medicine aimed at repairing and regenerating biological functions. Their commitment to innovative access and funding models highlights the transformative potential of these therapies in healthcare.
Highlighted product
Product
Genome Editing - Alliance for Regenerative Medicine
Metagenomi
Emeryville, United States
B
51-100 Employees
2018
Key takeaway
Metagenomi is developing potentially curative therapeutics through its metagenomics-powered gene editing toolbox, which utilizes undiscovered genetic material from natural environments. Their approach aims to create innovative genetic medicines by matching optimal gene editing tools to specific medical indications.
Highlighted product
Core business
Curative Gene Editing Forged From Nature | Metagenomi
Metagenomi is transforming novel gene editing tools, mined from the world’s natural microbial environment, into life-saving genetic medicines.
Technologies which have been searched by others and may be interesting for you:
Gene editing refers to a set of technologies that enable scientists to modify an organism's DNA. This process allows for the precise alteration of genes within living cells, facilitating the addition, deletion, or alteration of genetic material. Techniques such as CRISPR-Cas9 have revolutionized gene editing by providing a simpler and more efficient means to target specific genes, leading to advancements in various fields including medicine, agriculture, and biotechnology. The implications of gene editing are vast, offering potential solutions for genetic disorders, enhanced crop resilience, and improved understanding of biological processes. Ethical considerations surrounding gene editing are also significant, prompting ongoing discussions about its impact on future generations and ecosystems.
Gene editing is a powerful technology that allows scientists to alter an organism's DNA at specific locations in its genome. This process typically involves the use of molecular tools like CRISPR-Cas9, which can precisely target and modify genes. By creating a double-strand break in the DNA at a desired location, the natural repair mechanisms of the cell can be harnessed to either disrupt a gene or insert new genetic material. Once the DNA is cut, the cell's repair system kicks in, often leading to changes in the genetic code. These changes can result in the activation or deactivation of specific genes, effectively allowing for the modification of traits in various organisms. This technology is revolutionizing fields such as agriculture, medicine, and biotechnology, enabling advancements like disease-resistant crops and targeted therapies for genetic disorders.
Ethical concerns surrounding gene editing primarily focus on the implications of altering human DNA. One major issue is the potential for unintended consequences, such as off-target effects, which could lead to unforeseen health problems. Additionally, there is apprehension about the long-term effects on future generations, as changes made to germline cells may be passed down, raising questions about consent and the rights of unborn individuals. Another significant concern is the possibility of exacerbating social inequalities. Access to gene editing technologies may be limited to wealthier individuals, leading to a new form of genetic classism. Furthermore, the ability to edit genes for non-medical enhancements, such as physical appearance or intelligence, poses moral dilemmas about what constitutes "normal" and could prompt societal pressures to conform to specific genetic standards.
Gene editing offers transformative potential in medicine, enabling precise modifications to the genome. One significant application is in the development of targeted therapies for genetic disorders. By correcting mutations at the DNA level, gene editing can potentially cure conditions such as cystic fibrosis and sickle cell disease. Another application lies in cancer treatment. Gene editing techniques can be used to enhance the body’s immune response against tumors or to modify cancer cells directly, making them more susceptible to existing therapies. Additionally, gene editing holds promise in the field of regenerative medicine, where it could facilitate the repair or replacement of damaged tissues and organs, providing hope for conditions like heart disease and spinal cord injuries.
Gene editing carries several risks that need careful consideration. One significant concern is the potential for unintended genetic changes, known as "off-target effects." These can lead to harmful mutations or disruptions in other important genes, which may cause unforeseen health issues or complications. Another risk involves ethical implications and long-term consequences. As gene editing technology advances, questions arise about its use in humans, particularly concerning designer babies and the potential for exacerbating social inequalities. The long-term effects of gene editing on ecosystems and biodiversity also warrant attention, as altering organisms could disrupt existing ecological balances.
Some interesting numbers and facts about your company results for Gene Editing
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 6443 |
| Amount of suitable service providers | 5333 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2007 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Gene Editing?
Start-Ups who are working in Gene Editing are CRISPR AgroBio News (CARBON)
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are Biotechnology, IT, Software and Services, Other, Healthcare, Medical
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
